Načítám výsledky…
Sandoz 2025 full-year results are out, and I'm proud that we reached more than 1 billion patients with our medicines.
Richard Saynor, CEO of Sandoz, discusses the firm's half-year results and shares his outlook for innovation in the weight loss drug market.
Today, Sandoz announced strong results for H1 2025! These results are more than just numbers - they highlight our commitment to pioneering...
Claire D'Abreu-Hayling, Chief Scientific Officer at Sandoz, discusses the role of generics and biosimilars in reducing healthcare costs,...
As we continue to grow, we also continue to offer our colleagues flexible-hybrid working This is just one of our ways to recognize our...
Sandoz is going through an exciting and transformative period as a global leader and pioneering provider of sustainable generic and...
Her research focuses on uro-oncology and evidence-based clinical research, including collaborative prostate cancer research with The Royal...
Video · During #PrideMonth at Sandoz, we discussed how we can continue to build upon our culture to create a truly diverse and inclusive...
And you see some of the incredible innovation that the Pharmaceutical industry is bringing, particularly in this space is transforming patients...